324 related articles for article (PubMed ID: 25910916)
1. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
[TBL] [Abstract][Full Text] [Related]
2. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.
Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC
Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135
[TBL] [Abstract][Full Text] [Related]
3. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
[TBL] [Abstract][Full Text] [Related]
4. High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells.
Fernandes LS; Emerick GL; Ferreira RS; Santos NAGD; Santos ACD
Toxicol In Vitro; 2017 Mar; 39():84-92. PubMed ID: 27939611
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds.
Hong MS; Hong SJ; Barhoumi R; Burghardt RC; Donnelly KC; Wild JR; Venkatraj V; Tiffany-Castiglioni E
Toxicol Appl Pharmacol; 2003 Jan; 186(2):110-8. PubMed ID: 12639502
[TBL] [Abstract][Full Text] [Related]
7. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
8. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter.
Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E
Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro study of the inhibition of human and hen esterases by methamidophos enantiomers.
Emerick GL; DeOliveira GH; Oliveira RV; Ehrich M
Toxicology; 2012 Feb; 292(2-3):145-50. PubMed ID: 22198100
[TBL] [Abstract][Full Text] [Related]
11. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
Ehrich M; Correll L; Veronesi B
Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
[TBL] [Abstract][Full Text] [Related]
13. L- and T-type calcium channel blockers protect against the inhibitory effects of mipafox on neurite outgrowth and plasticity-related proteins in SH-SY5Y cells.
Fernandes LS; Dos Santos NAG; Emerick GL; Santos ACD
J Toxicol Environ Health A; 2017; 80(19-21):1086-1097. PubMed ID: 28862523
[TBL] [Abstract][Full Text] [Related]
14. Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.
Massicotte C; Knight K; Van der Schyf CJ; Jortner BS; Ehrich M
Neurotox Res; 2005; 7(3):203-17. PubMed ID: 15897155
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
16. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters.
Ehrich M; Correll L
J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941
[TBL] [Abstract][Full Text] [Related]
18. The Antidiabetic Drug Liraglutide Minimizes the Non-Cholinergic Neurotoxicity of the Pesticide Mipafox in SH-SY5Y Cells.
Fernandes LS; Dos Santos NAG; Emerick GL; Dos Santos AC
Neurotox Res; 2019 Jan; 35(1):150-159. PubMed ID: 30088187
[TBL] [Abstract][Full Text] [Related]
19. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
Kropp TJ; Richardson RJ
J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells.
Cho T; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2004 Jul; 67(13):987-1000. PubMed ID: 15205030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
